Treatment type

GLP-1

Glucagon-like peptide-1 (and dual GIP/GLP-1) medicines for diabetes, weight, and labelled organ-protection uses. Authorized is not funded.

All New Developments

GLP-1 breakthroughs

All countriesUnited StatesCanadaUnited KingdomJapanChinaAustraliaSwitzerlandEuropean UnionNewestPatient Stories

No published breakthroughs for Japan yet. International pieces stay on All countries. We are not filling this zoom with placeholder access.